 |
市场调查报告书
商品编码
1411680
登革热检测市场：按类型、组件和最终用户划分 - 2024-2030 年全球预测Dengue Testing Market by Type (Dengue IgG/IgM Rapid Test, ELISA-based Test, Real-Time RT-PCR Test), Component (Instruments & Equipments, Laboratory Consumables, Software & Data Management Solutions), End-User - Global Forecast 2024-2030 |
||||||
价格
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年登革热检测市场规模为4.9978亿美元，2024年将达5.2702亿美元，2030年将达7.3769亿美元，复合年增长率为5.71%。
登革热检测的全球市场
| 主要市场统计 | |
|---|---|
| 基准年[2023] | 4.9978 亿美元 |
| 预测年份 [2024] | 52702万美元 |
| 预测年份 [2030] | 73769万美元 |
| 复合年增长率（%） | 5.71% |
FPNV定位矩阵
FPNV定位矩阵对于评估登革热侦测市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。
市场占有率分析
市场占有率分析是一种综合工具，可以对登革热测试市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。
该报告对以下几个方面提供了宝贵的见解：
1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。
2-市场开拓：我们深入研究利润丰厚的新兴市场并分析其在成熟细分市场的渗透率。
3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。
本报告解决了以下关键问题：
1-登革热检测市场的市场规模和预测是多少？
2-在登革热检测市场的预测期内，需要考虑投资哪些产品、细分市场、应用和领域？
3-登革热检测市场的技术趋势和法律规范是什么？
4-登革热检测市场主要供应商的市场占有率是多少？
5-进入登革热检测市场的适当型态和策略手段是什么？
目录
第一章 前言
第二章调查方法
第三章执行摘要
第四章市场概况
第五章市场洞察
- 市场动态
- 促进因素
- 人群中登革热感染疾病的发生率增加
- 扩大政府努力提高医疗保健意识
- 增加每个国家的医疗基础设施和支出
- 抑制因素
- 诊断套件和测试相关的高成本
- 机会
- 强力研发先进登革热检测套件
- 消除蚊媒登革热的新测试模型的演变
- 任务
- 对现有测试方法的有效性和有效性的担忧
- 促进因素
- 市场区隔分析
- 市场趋势分析
- 高通膨的累积效应
- 波特五力分析
- 价值炼和关键路径分析
- 法律规范
第六章登革热检测市场：按类型
- 登革热 IgG/IgM 快速检测
- 基于 ELISA 的测试
- 实时RT-PCR检测
第七章登革热检测市场：依组成部分
- 设备与设备
- 实验耗材
- 软体和资料管理解决方案
第八章登革热检测市场：依最终用户分类
- 诊断中心
- 医院
- 调查机构
第九章 北美、南美登革热检测市场
- 阿根廷
- 巴西
- 加拿大
- 墨西哥
- 美国
第十章 亚太地区登革热检测市场
- 澳洲
- 中国
- 印度
- 印尼
- 日本
- 马来西亚
- 菲律宾
- 新加坡
- 韩国
- 台湾
- 泰国
- 越南
第十一章 欧洲、中东和非洲登革热检测市场
- 丹麦
- 埃及
- 芬兰
- 法国
- 德国
- 以色列
- 义大利
- 荷兰
- 奈及利亚
- 挪威
- 波兰
- 卡达
- 俄罗斯
- 沙乌地阿拉伯
- 南非
- 西班牙
- 瑞典
- 瑞士
- 土耳其
- 阿拉伯聯合大公国
- 英国
第十二章竞争形势
- FPNV定位矩阵
- 市场占有率分析：主要企业
- 主要企业竞争情境分析
第13章竞争产品组合
- 主要公司简介
- Abbott Laboratories
- Abnova Corporation
- Biogenix Inc. Pvt. Ltd.
- Biolab Diagnostics{I}Pvt. Ltd.
- Biopanda Reagents Ltd.
- Certest Biotec, SL
- DiaSorin SpA
- EUROIMMUN Medizinische Labordiagnostika AG
- F. Hoffmann-La Roche Ltd.
- Getein Biotech, Inc.
- InBios International, Inc.
- Intec Products, Inc.
- Lexicare Pharma Pvt. Ltd.
- NovaTec Immundiagnostica GmbH
- OriGene Technologies, Inc.
- Quest Diagnostics
- Reckon Diagnostics Pvt. Ltd.
- Reliable Pro-detect Biomedicals Pvt. Ltd.
- Saheb Pharmaceuticals LLP
- Sri Pharmacare
- Thermo Fisher Scientific Inc.
- 主要产品系列
第十四章附录
- 讨论指南
- 关于许可证和定价
Product Code: MRR-69324464D112
[181 Pages Report] The Dengue Testing Market size was estimated at USD 499.78 million in 2023 and expected to reach USD 527.02 million in 2024, at a CAGR 5.71% to reach USD 737.69 million by 2030.
Global Dengue Testing Market
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 499.78 million |
| Estimated Year [2024] | USD 527.02 million |
| Forecast Year [2030] | USD 737.69 million |
| CAGR (%) | 5.71% |
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Dengue Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Dengue Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Dengue Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abnova Corporation, Biogenix Inc. Pvt. Ltd., Biolab Diagnostics {I}Pvt. Ltd., Biopanda Reagents Ltd., Certest Biotec, S.L., DiaSorin S.p.A., EUROIMMUN Medizinische Labordiagnostika AG, F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., InBios International, Inc., Intec Products, Inc., Lexicare Pharma Pvt. Ltd., NovaTec Immundiagnostica GmbH, OriGene Technologies, Inc., Quest Diagnostics, Reckon Diagnostics Pvt. Ltd., Reliable Pro-detect Biomedicals Pvt. Ltd., Saheb Pharmaceuticals LLP, Sri Pharmacare, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Dengue Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Type
- Dengue IgG/IgM Rapid Test
- ELISA-based Test
- Real-Time RT-PCR Test
- Component
- Instruments & Equipments
- Laboratory Consumables
- Software & Data Management Solutions
- End-User
- Diagnostic Centers
- Hospitals
- Research Institutes
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Dengue Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Dengue Testing Market?
3. What are the technology trends and regulatory frameworks in the Dengue Testing Market?
4. What is the market share of the leading vendors in the Dengue Testing Market?
5. Which modes and strategic moves are suitable for entering the Dengue Testing Market?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
- 4.1. Introduction
- 4.2. Dengue Testing Market, by Region
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing incidences of dengue infections among population
- 5.1.1.2. Growing government initiatives promoting healthcare awareness
- 5.1.1.3. Rise in healthcare infrastructure and spendings across economies
- 5.1.2. Restraints
- 5.1.2.1. High costs associated with diagnostic kits and tests
- 5.1.3. Opportunities
- 5.1.3.1. Robust research and development of advanced dengue detection kits
- 5.1.3.2. Evolution of new testing model to swat mosquito-borne dengue fever
- 5.1.4. Challenges
- 5.1.4.1. Concerns over efficacy and effectiveness of existing testing methods
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
6. Dengue Testing Market, by Type
- 6.1. Introduction
- 6.2. Dengue IgG/IgM Rapid Test
- 6.3. ELISA-based Test
- 6.4. Real-Time RT-PCR Test
7. Dengue Testing Market, by Component
- 7.1. Introduction
- 7.2. Instruments & Equipments
- 7.3. Laboratory Consumables
- 7.4. Software & Data Management Solutions
8. Dengue Testing Market, by End-User
- 8.1. Introduction
- 8.2. Diagnostic Centers
- 8.3. Hospitals
- 8.4. Research Institutes
9. Americas Dengue Testing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Dengue Testing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Dengue Testing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Abnova Corporation
- 13.1.3. Biogenix Inc. Pvt. Ltd.
- 13.1.4. Biolab Diagnostics {I}Pvt. Ltd.
- 13.1.5. Biopanda Reagents Ltd.
- 13.1.6. Certest Biotec, S.L.
- 13.1.7. DiaSorin S.p.A.
- 13.1.8. EUROIMMUN Medizinische Labordiagnostika AG
- 13.1.9. F. Hoffmann-La Roche Ltd.
- 13.1.10. Getein Biotech, Inc.
- 13.1.11. InBios International, Inc.
- 13.1.12. Intec Products, Inc.
- 13.1.13. Lexicare Pharma Pvt. Ltd.
- 13.1.14. NovaTec Immundiagnostica GmbH
- 13.1.15. OriGene Technologies, Inc.
- 13.1.16. Quest Diagnostics
- 13.1.17. Reckon Diagnostics Pvt. Ltd.
- 13.1.18. Reliable Pro-detect Biomedicals Pvt. Ltd.
- 13.1.19. Saheb Pharmaceuticals LLP
- 13.1.20. Sri Pharmacare
- 13.1.21. Thermo Fisher Scientific Inc.
- 13.2. Key Product Portfolio
14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
LIST OF FIGURES
- FIGURE 1. DENGUE TESTING MARKET RESEARCH PROCESS
- FIGURE 2. DENGUE TESTING MARKET SIZE, 2023 VS 2030
- FIGURE 3. DENGUE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. DENGUE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. DENGUE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. DENGUE TESTING MARKET DYNAMICS
- FIGURE 7. DENGUE TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. DENGUE TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. DENGUE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
- FIGURE 10. DENGUE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. DENGUE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. DENGUE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. DENGUE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. DENGUE TESTING MARKET SHARE, BY KEY PLAYER, 2023
LIST OF TABLES
- TABLE 1. DENGUE TESTING MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. DENGUE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL DENGUE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 6. DENGUE TESTING MARKET SIZE, BY DENGUE IGG/IGM RAPID TEST, BY REGION, 2018-2030 (USD MILLION)
- TABLE 7. DENGUE TESTING MARKET SIZE, BY ELISA-BASED TEST, BY REGION, 2018-2030 (USD MILLION)
- TABLE 8. DENGUE TESTING MARKET SIZE, BY REAL-TIME RT-PCR TEST, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 10. DENGUE TESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. DENGUE TESTING MARKET SIZE, BY LABORATORY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. DENGUE TESTING MARKET SIZE, BY SOFTWARE & DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 14. DENGUE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. DENGUE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. DENGUE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. AMERICAS DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 20. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 21. ARGENTINA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 22. ARGENTINA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 23. ARGENTINA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 24. BRAZIL DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 25. BRAZIL DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 26. BRAZIL DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 27. CANADA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 28. CANADA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 29. CANADA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 30. MEXICO DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 31. MEXICO DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 32. MEXICO DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 33. UNITED STATES DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 34. UNITED STATES DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 35. UNITED STATES DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 36. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 37. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 38. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 39. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 40. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 41. AUSTRALIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 42. AUSTRALIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 43. AUSTRALIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 44. CHINA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 45. CHINA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 46. CHINA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 47. INDIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 48. INDIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 49. INDIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 50. INDONESIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 51. INDONESIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 52. INDONESIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 53. JAPAN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 54. JAPAN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 55. JAPAN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 56. MALAYSIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 57. MALAYSIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 58. MALAYSIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 59. PHILIPPINES DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 60. PHILIPPINES DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 61. PHILIPPINES DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 62. SINGAPORE DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 63. SINGAPORE DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 64. SINGAPORE DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 65. SOUTH KOREA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 66. SOUTH KOREA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 67. SOUTH KOREA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 68. TAIWAN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 69. TAIWAN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 70. TAIWAN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 71. THAILAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 72. THAILAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 73. THAILAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 74. VIETNAM DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 75. VIETNAM DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 76. VIETNAM DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 77. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 78. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 79. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 80. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 81. DENMARK DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 82. DENMARK DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 83. DENMARK DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 84. EGYPT DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 85. EGYPT DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 86. EGYPT DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 87. FINLAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 88. FINLAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 89. FINLAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 90. FRANCE DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 91. FRANCE DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 92. FRANCE DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 93. GERMANY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 94. GERMANY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 95. GERMANY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 96. ISRAEL DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 97. ISRAEL DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 98. ISRAEL DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 99. ITALY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 100. ITALY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 101. ITALY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 102. NETHERLANDS DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 103. NETHERLANDS DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 104. NETHERLANDS DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 105. NIGERIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 106. NIGERIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 107. NIGERIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 108. NORWAY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 109. NORWAY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 110. NORWAY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 111. POLAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 112. POLAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 113. POLAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 114. QATAR DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 115. QATAR DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 116. QATAR DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 117. RUSSIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 118. RUSSIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 119. RUSSIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 120. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 121. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 122. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 123. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 124. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 125. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 126. SPAIN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 127. SPAIN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 128. SPAIN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 129. SWEDEN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 130. SWEDEN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 131. SWEDEN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 132. SWITZERLAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 133. SWITZERLAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 134. SWITZERLAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 135. TURKEY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 136. TURKEY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 137. TURKEY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 138. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 139. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 140. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 141. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 142. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
- TABLE 143. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 144. DENGUE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
- TABLE 145. DENGUE TESTING MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 146. DENGUE TESTING MARKET LICENSE & PRICING
